Literature DB >> 21088472

Serum uric acid in relation with the metabolic syndrome components and adiponectin levels in Lebanese University students.

R Chedid1, F Zoghbi, G Halaby, M-H Gannagé-Yared.   

Abstract

BACKGROUND: The relation between serum uric acid (SUA) and metabolic syndrome (MetS) parameters has never been studied in a young Middle-Eastern population. In addition, the relation between SUA and adiponectin was poorly studied.
METHODS: We looked at the relation between SUA, and both adiponectin and MetS components in 381 randomly selected Lebanese university students (201 males and 180 females).
RESULTS: SUA was positively correlated with body mass index (BMI), systolic blood pressure (SBP), diastolic blood pressure (DBP), waist circumference (WC), fasting blood glucose (FPG), triglycerides, total and LDL-cholesterol, and homeostasis model assessment (HOMA) index (p<0.001 for all variables, p<0.01 for FPG) and inversely correlated with HDL-cholesterol and adiponectin (p<0.001 for both variables). In men, SUA was positively correlated with BMI, WC, SBP, DBP, FPG, triglycerides, total and LDL-cholesterol, and HOMA index and inversely correlated with adiponectin (p<0.001 for all variables, p<0.05 for adiponectin); these correlations persisted after BMI adjustment, for WC, FPG, triglycerides, total-cholesterol, LDL-cholesterol, and HOMA index. In women, SUA was positively correlated with total and LDL-cholesterol (p<0.001), independently of BMI. In a multiple regression analysis, SUA was independently associated with WC, triglycerides, total cholesterol, HDLcholesterol and adiponectin in the overall population while, in men, it was associated with triglycerides, total-cholesterol, and WC.
CONCLUSION: Our results suggest, in young adults, a gender difference in the relation between SUA and both adiponectin and MetS parameters. In addition, we observed in both genders a strong relation of SUA with total cholesterol. Further studies are needed in larger populations in order to elucidate these findings.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21088472     DOI: 10.3275/7350

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  39 in total

1.  Differential association of adiponectin with cardiovascular risk markers in men and women? The KORA survey 2000.

Authors:  W Rathmann; B Haastert; C Herder; H Hauner; W Koenig; C Meisinger; R Holle; G Giani
Journal:  Int J Obes (Lond)       Date:  2006-11-21       Impact factor: 5.095

Review 2.  Essential hypertension, progressive renal disease, and uric acid: a pathogenetic link?

Authors:  Richard J Johnson; Mark S Segal; Titte Srinivas; Ahsan Ejaz; Wei Mu; Carlos Roncal; Laura G Sánchez-Lozada; Michael Gersch; Bernardo Rodriguez-Iturbe; Duk-Hee Kang; Jaime Herrera Acosta
Journal:  J Am Soc Nephrol       Date:  2005-04-20       Impact factor: 10.121

3.  Effects of a fenofibrate/losartan combination on the plasma concentration and urinary excretion of purine bases.

Authors:  T Ka; T Inokuchi; Z Tsutsumi; S Takahashi; Y Moriwaki; T Yamamoto
Journal:  Int J Clin Pharmacol Ther       Date:  2006-01       Impact factor: 1.366

Review 4.  The role of statins for the primary and secondary prevention of coronary heart disease in women.

Authors:  Konstantinos Tziomalos; Anna I Kakafika; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

5.  Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study.

Authors:  Leo K Niskanen; David E Laaksonen; Kristiina Nyyssönen; Georg Alfthan; Hanna-Maaria Lakka; Timo A Lakka; Jukka T Salonen
Journal:  Arch Intern Med       Date:  2004-07-26

6.  Relationship between the serum uric acid level, visceral fat accumulation and serum adiponectin concentration in Japanese men.

Authors:  Sachiko Tamba; Hitoshi Nishizawa; Tohru Funahashi; Yukiyoshi Okauchi; Tomoko Ogawa; Midori Noguchi; Koichi Fujita; Miwa Ryo; Shinji Kihara; Hiromi Iwahashi; Kazuya Yamagata; Tadashi Nakamura; Iichiro Shimomura; Yuji Matsuzawa
Journal:  Intern Med       Date:  2008-07-01       Impact factor: 1.271

7.  Prevalence of the metabolic syndrome in individuals with hyperuricemia.

Authors:  Hyon K Choi; Earl S Ford
Journal:  Am J Med       Date:  2007-05       Impact factor: 4.965

8.  Uric acid and the development of metabolic syndrome in women and men.

Authors:  Xuemei Sui; Timothy S Church; Rebecca A Meriwether; Felipe Lobelo; Steven N Blair
Journal:  Metabolism       Date:  2008-06       Impact factor: 8.694

9.  Independent impact of gout on mortality and risk for coronary heart disease.

Authors:  Hyon K Choi; Gary Curhan
Journal:  Circulation       Date:  2007-08-13       Impact factor: 29.690

10.  Relatively high levels of serum adiponectin in obese women, a potential indicator of anti-inflammatory dysfunction: relation to sex hormone-binding globulin.

Authors:  Altan Onat; Gülay Hergenç; Dursun Dursunoğlu; Zekeriya Küçükdurmaz; Serkan Bulur; Günay Can
Journal:  Int J Biol Sci       Date:  2008-07-25       Impact factor: 6.580

View more
  3 in total

1.  Xanthine oxidase and cardiovascular risk in obese children.

Authors:  Harrison K Tam; Aaron S Kelly; Andrea M Metzig; Julia Steinberger; L'Aurelle A Johnson
Journal:  Child Obes       Date:  2014-02-25       Impact factor: 2.992

2.  A Prospective Follow-Up of Adipocytokines in Cohort Patients With Gout: Association With Metabolic Syndrome But Not With Clinical Inflammatory Findings: Strobe-Compliant Article.

Authors:  Sergio García-Méndez; Carolina Bustos Rivera-Bahena; José Luis Montiel-Hernández; Daniel Xibillé-Friedmann; Everardo Álvarez-Hernández; Ingris Peláez-Ballestas; Rubén Burgos-Vargas; Janitzia Vázquez-Mellado
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

3.  Assessing the Causal Effects of Adipokines on Uric Acid and Gout: A Two-Sample Mendelian Randomization Study.

Authors:  Ruyi Cong; Xiaoyu Zhang; Zihong Song; Shanshan Chen; Guanhua Liu; Yizhi Liu; Xiuyu Pang; Fang Dong; Weijia Xing; Youxin Wang; Xizhu Xu
Journal:  Nutrients       Date:  2022-03-05       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.